To include your compound in the COVID-19 Resource Center, submit it here.

Syros, SteadyMed complete private placements

Cancer company Syros Pharmaceuticals Inc. (NASDAQ:SYRS) and drug delivery play SteadyMed Ltd. (NASDAQ:STDY) raised a total of $65 million in private placements on

Read the full 234 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE